| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC | Sr. VP of Clinical Development | Common Stock | 46,405 | $2,148,514 | $46.30 | 21 Jan 2026 | Direct |
| SOLENO THERAPEUTICS INC | Sr. VP of Clinical Development | Employee stock option (right to buy) | 11,900 | 21 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | 21 Jan 2026 | 2 | $0 | 4 | Sr. VP of Clinical Development | 23 Jan 2026, 18:02 |
| SLNO | SOLENO THERAPEUTICS INC | 15 Dec 2025 | 1 | -$40,559 | 4 | Sr. VP of Clinical Development | 17 Dec 2025, 16:36 |
| SLNO | SOLENO THERAPEUTICS INC | 27 Mar 2025 | 11 | -$794,327 | 4 | Sr. VP of Clinical Development | 31 Mar 2025, 19:18 |
| SLNO | SOLENO THERAPEUTICS INC | 21 Jan 2025 | 2 | $0 | 4 | Sr. VP of Clinical Development | 23 Jan 2025, 16:25 |
| SLNO | SOLENO THERAPEUTICS INC | 17 Jul 2024 | 1 | $0 | 4 | Sr. VP of Clinical Development | 19 Jul 2024, 09:03 |
| SLNO | SOLENO THERAPEUTICS INC | 22 Apr 2024 | 0 | $0 | 3 | Sr. VP of Clinical Development | 30 Apr 2024, 17:53 |